RET and medullary thyroid gland carcinoma: In particular, we used a specific anti-miRNA that targets miR-21 to suppress the expression of miR-21, examining the possible effects on two reference cancer cell lines for MTC: TT cells carrying a RET C634W mutation and MZ-CRC-1 cells carrying a RET M918T mutation.